EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

The Molecular Heterogeneity of NRAS Variants in Thyroid Nodules

Emma De Ravin iD, Mohammed Alshalalfa, Ruochen Jiang, Yangyang Hao, Joshua P Klopper, Elizabeth Cottrill

Otolaryngology–Head and Neck Surgery · 2026-08 · 175 (2) · 343-349

DOI: 10.1002/ohn.70298 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Otolaryngology–Head and Neck Surgery, online erschienen am 17.06.2026. Verfasst von Emma De Ravin und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology-Head and Neck Surgery, Thomas Jefferson University, Philadelphia, Pennsylvania, USA. Hauptthemen laut MEDLINE: GTP Phosphohydrolases, Membrane Proteins, Thyroid Nodule, Mutation. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

NRAS variants are the most common mutations in thyroid nodules with (B)ethesda III/IV cytology. This study aims to characterize co‐occurring variants, molecular signatures, and hallmarks of cancer pathways in nodules with NRAS variants. Study Design Retrospective database analysis.

Methods

The database of nodules sent for Afirma GSC testing was analyzed for the most common NRAS hotspot mutations, co‐occurring mutations, BRAF‐RAS score (BRS), thyroid differentiation score (TDS), ERK expression, and activity levels of hallmarks of cancer pathways.

Results

Of 87,817 Afirma GSC‐suspicious or BV/VI nodules, 12.6% had NRAS mutations. Of those, 79.7% were NRAS p.Q61R and 19.4% were NRAS p.Q61K. 421 nodules (3.8%) had co‐occurring mutations, EIF1AX being the most common (1%, about twice the rate seen alone). Of 872 nodules with TERT promoter mutations ( TERTp ), 7.8% had concurrent NRAS + TERT mutations (more than twice the rate of TERT alone). The presence of NRAS (+/− co‐mutations) was highly RAS‐ like on the BRS score. Hallmarks of cancer pathways analyzed across NRAS + nodules, with TERTp profiling, revealed 2 distinct clusters: one with higher inflammatory pathway activity, and another with higher DNA repair, estrogen response, and MYC activity. The latter had a higher rate of BV/VI nodules. NRAS p.Q61R was equally distributed across the 2 clusters.

Conclusion

NRAS p.Q61R/K comprises 99% of reported NRAS variants. TERTp is the most frequent co‐mutation. Among NRAS p.Q61R/K nodules, there are 2 different clusters of samples based on the activity of hallmarks of cancer pathways. Further studies correlating these clusters with clinical and pathological outcomes are necessary.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GTP PhosphohydrolasesMembrane ProteinsThyroid NoduleMutationHumansRetrospective StudiesTelomerase

Stichwörter der Autor:innen

NRAS mutationgene expression profilingmolecular diagnostic techniquesthyroid nodule

Substanzen

GTP PhosphohydrolasesNRAS protein, humanMembrane ProteinsTelomerase

Autor:innen und Institutionen

  • Department of Otolaryngology-Head and Neck Surgery, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.
  • Veracyte Inc., South San Francisco, California, USA.

ORCID-Profile: Emma De Ravin

Zitieren

APA

Ravin, E., Alshalalfa, M., Jiang, R., Hao, Y., Klopper, J. P., & Cottrill, E. (2026). The Molecular Heterogeneity of NRAS Variants in Thyroid Nodules. Otolaryngology–Head and Neck Surgery, 175(2), 343-349. https://doi.org/10.1002/ohn.70298

Vancouver

Ravin E, Alshalalfa M, Jiang R, Hao Y, Klopper JP, Cottrill E. The Molecular Heterogeneity of NRAS Variants in Thyroid Nodules. Otolaryngology–Head and Neck Surgery. 2026;175(2):343-349. doi:10.1002/ohn.70298

BibTeX
@article{Ravin2026,
  author = {Ravin, Emma De and Alshalalfa, Mohammed and Jiang, Ruochen and Hao, Yangyang and Klopper, Joshua P and Cottrill, Elizabeth},
  title = {The Molecular Heterogeneity of NRAS Variants in Thyroid Nodules},
  journal = {Otolaryngology–Head and Neck Surgery},
  year = {2026},
  volume = {175},
  number = {2},
  pages = {343--349},
  doi = {10.1002/ohn.70298}
}
Kostenlos starten →